Praharshinie Rupasinghe

Also affiliated with Research Institute for Tropical Medicine, Mount Sinai Medical Center, Instituut voor Tropische Geneeskunde, Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures, University of Tübingen, Icahn School of Medicine at Mount Sinai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial”.

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00194-8

N/A

0.781DataRank · unranked

26 citations

Uzma Khan, Gustavo E. Velásquez, Maëlenn Gouillou, Muhammad Hammad Ali, Samreen Amjad +95 more